title: Should intravenous thrombolysis be considered the first option in pregnant women?
authors: Department of Neurology, University of Cincinnati Neuroscience Institute, Cincinnati, OH 45221, USA. joseph.Broderick@uc.edu
authors: Joseph P
authors: JP
authors: Broderick
mesh_terms: D057510:Endovascular Procedures; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D018570:Risk Assessment; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator